Transcriptional regulation of the human chromogranin A gene by its 5' distal regulatory element: Novel effects of orientation, structure, flanking sequences, and position on expression

Molecular and Cellular Endocrinology

Volumn 124, Issue 1-2, 1996, Pages 51-62

  Nolan, E M ^a   Cheung, T C ^a   Burton, D W ^a   Deftos, L J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AP 1; Chromogranin A; Gene expression; Neuroendocrine; Transfection

Indexed keywords

CHROMOGRANIN A; NUCLEAR FACTOR;

ARTICLE; BINDING SITE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA FLANKING REGION; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; HUMAN; HUMAN CELL; NEUROSECRETORY CELL; NUCLEOTIDE SEQUENCE; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA BINDING; REGULATOR GENE; TATA BOX; TRANSCRIPTION REGULATION;

EID: 0030606099     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(96)03927-5     Document Type: Article

References (37)

1. [1] Deftos, L.J. (1991 ) Chromogranin A: its role in endocrine function and as a endocrine and neuroendocrine tumor marker. Endocr. Rev. 12, 181-187.
2. [2] Winkler, H. and Fisher-Colbrie, R. (1992) The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49, 497-528.
3. [3] Brandt, D.W., Burton, D.W., Hogue-Angeletti, R. and Deftos, L.J. (1993) Chromogranin A peptide-specific antisera and high-performance size exclusion chromatography demonstrate amino-terminal and carboxy-terminal fragments of the native molecule in human cell lines. Proc. Soc. Exp. Biol. Med. 305, 316-320.
4. [4] Deftos, L.J., Fieck, A., Burton, D.W., Tu, S., Ditmer, L.S., Petrin, E.M., Bohuon, C., Smeekins, S.P. and Brandt, D.W. (1993) Expression of the endoproteolytic convertases by endocrine and neuroendocrine tumors. Endocr. J. 1, 285-289.
5. [5] O'Connor, D.T. and Deftos, L.J. (1986) Secretion of chromogranin A by peptide-producing endocrine neoplasms. N. Engl. J. Med. 314, 1145-1151.
6. [6] Deftos, L.J., Nakada, S., Burton, D.W., di Sant' Agnese, P.A., Cockett, A.T.K. and Abrahamsson, P.A. (1996) Immunoassay and immunohistology studies of chromogranin A as a neuroendocrine marker in patients with carcinoma of the prostate. Urology 48, 58-62.
7. [7] Nolan, E.M., Helman, L.J. and Deftos, L.J. (1994) Cloning of the human chromogranin-A promoter and identification of a sequence that possesses enhancer-like activity. Endocr. J. 2, 891-897.
8. [8] Nolan, E.M., Cheung, T.C., Burton, D.W. and Deftos, L.J. (1995) Identification and characterization of a neuroendocrine-specific 5′ regulatory region of the human chromogranin A gene. Endocrinology 136, 5632-5642.
9. [9] Chiu, R., Imagawa, M., Imbra, R.J., Bockoven, J.R. and Karin, M. (1987) Multiple cis- and transacting elements mediate the transcriptional response to phorbol esters. Nature 329, 648-651.
10. [10] Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R.J., Rahmsdorf, H.J., Jonat, C., Herrlich, P. and Karin, M. (1987) Phorbol ester-induced genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49, 729-739.
11. [11] Fung, B.P., Yoon, S.O. and Chikaraishi, D.M. (1992) Sequences that direct rat tyrosine hydroxylase gene expression. J. Neurochem. 58, 2044-2052.
12. [12] Ishiguro, H., Kim, K.T., Joh, T.H. and Kim, K.-S. (1993) Neuron-specific expression of the human dopamine β-hydoxylase gene requires both the c-AMP-response element and a silencer region. J. Biol. Chem. 268, 17987-17994.
13. [13] Evers, B.M., Wang, X., Zhou, Z., Townsend Jr. C.M., Mcneil, G.P. and Dobner, P.R. (1995) Characterization of promoter elements required for cell-specific expression of the neurotensin/ neuromedin N gene in a human endocrine cell line. Mol. Cell Biol. 15, 3870-3881.
14. [14] Seiden, R.F., Howie, K.B., Rowe, M.E., Goodman, H.M. and Moore, D.D. (1993) Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell Biol. 6, 3173-3179.
15. [15] Eustice, D.C., Feldman, P.A., Colberg-Poley, A.M., Buckery, R.M. and Neubauer, R.H. (1991) A sensitive method for the detection of ß-galactosidase in transfected mammalian cells. Biotechniques 11, 729-742.
16. [16] Chen, W.Y., Chen, N.-Y., Yun, J., Wagner, T.E. and Kopchick, J.J. (1994) In vitro and in vivo studies of antagonistic effects of human growth hormone analogs. J. Biol. Chem. 269, 15892-15897.
17. [17] Brandt, D.W., Wachsman, W. and Deftos, L.J. (1994) Parathyroid hormone-like protein alternative mRNA splicing pathways in human cancer cell lines. Cancer Res. 54, 850-853.
18. [18] Dingham, J.D., Lebovitz, R.M. and Roeder, R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489.
19. [19] Lee, W., Mitchell, P. and Tjian, R. (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49, 741-752.
20. [20] Glover, M. and Harrison, S.C. (1995) Crystal structure of the heterodimeric bZIP transcription factor c-fos-c-jun bound to DNA. Nature 373, 257-261.
21. [21] Nimer, S., Fraser, J., Richards, J., Lynch, M. and Gasson, J. (1990) The repeated sequence CATT(A/T) is required for granulocyte-macrophage colony-stimulating factor promoter activity. Mol. Cell. Biol. 10, 6084-6088.
22. [22] Fraser, J.K., Tran, S., Nimer, S.D. and Gasson, J.C. (1994) Characterization of nuclear factors that bind to a critical positive regulatory element of the human granulocyte-macrophage colony-stimulating factor promoter. Blood 84, 2523-2530.
23. [23] Risse, G., Jooss, K., Neuberg, M., Bruller, H.-J. and Muller, R. (1989) Asymmetrical recognition of the palindromic AP-1 binding site (TRE) by Fos protein complexes. EMBO J. 8, 3825-3832.
24. [24] Stein, B., Baldwin Jr. A.S., Ballard, D.W., Greene, W.C., Angel, P. and Herrlich, P. (1993) Cross-coupling of the NFkB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12, 3879-3891.
25. [25] Kawana, M., Lee, M.-E., Quertermous, E.E. and Quertermous, T. (1995) Cooperative interaction of GATA-2 and AP-1 regulates transcription of the endothelin-1 gene. Mol. Cell. Biol. 15, 4225-4231.
26. [26] Wu, H., Moulton, K., Horval, A., Parik, S. and Glass, C.K. (1994) Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene. Mol. Cell. Biol. 14, 2129-2139.
27. [27] Wasylyk, B., Wasylyk, C., Flores, P., Begue, A., Leprince, D. and Stehelin, D. (1990) The c-ets prot-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcription activation. Nature 346, 191-193.
28. [28] Nakae, K., Nakajima, K., Inazawa, J., Kitaoka, T. and Hirano, T. (1995) ERM, a PEA3 subfamily of ets transcription factors, can cooperate with c-Jun. J. Biol. Chem. 270, 23795-23800.
29. [29] Wu, H., Mahata, S.K., Mahata, M., Webster, N.J.G., Parmer, R.J. and O'Connor, D.T. (1995) A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A. J. Clin. Invest. 96, 568-578.
30. [30] Mouland, A.J., Bevan, S., White, J.H. and Hendy, G.N. (1994) Human chromogranin A gene: molecular cloning, structural analysis, and neuroendocrine cell-specific expression. J. Biol. Chem. 269, 6918-6926.
31. [31] Chen, L., Oakley, M.G., Glover, J.N.M., Jain, J., Dervan, P.B., Hogan, P.G., Rao, A. and Verdine, G.L. (1995) Only one of the two DNA-bound orientations of AP-1 found is solution cooperates with NFATp. Curr. Biol. 5, 882-889.
32. IIS directing synergistic activation of transcription. Science 270, 1783-1788.
33. [33] Iacangelo, A.L., Grimes, M. and Eiden, L.E. (1991) The bovine chromogranin A gene: structural basis for hormone regulation and generation of biologically active peptides. Mol. Endocrinol. 5, 1651-1660.
34. [34] Rozansky, D.L., Wu, H., Tang, K., Parmer, R.J. and O'Connor, D.T. (1994) Glucocorticoid activation of chromogranin A gene expression. Identification and characterization of a novel glucocorticoid element. J. Clin. Invest. 94, 2357-2368.
35. [35] Wu, H., Rozansky, D.J., Parmer, R.J., Gill, B.M. and O'Connor, D.T. (1991) Structure and function of the chromogranin A gene. Clues to evolution and tissue-specific expression. J. Biol. Chem. 266, 13130-13134.
36. [36] Brandeis, M., Keshet, F.D., Siegfried, Z., Mendelsohn, M., Nemes, A., Temper, V., Razin, A. and Cedar, H. (1994) Sp1 elements protect a CpG island from de novo methylation. Nature 371, 435-438.
37. [37] Wu, H., Rozansky, D.J., Webster, N.J.G. and O'Connor, D.T. (1994) Cell type specific expression in the neuroendocrine system. A neuroendocrine-specific regulatory element in the promoter of chromogranin A, a ubiquitous secretory granile core protein. J. Clin. Invest. 94, 118-129.